AMR Alliance Follows Up Global Industry Standard With Responsible Manufacturing Certification
BSI Certification Is Open To Any Manufacturer, For Any Drug
Executive Summary
A new voluntary certification from the AMR Industry Alliance and the British Standards Institution will assess pharmaceutical firms’ responsibility and sustainability when it comes to manufacturing antibiotic drugs, in an attempt to control the spread of antimicrobial resistance.
You may also be interested in...
New Pricing Policies Needed To Curb AMR Impact, States Industry Alliance Report
The AMR Industry Alliance has put forward six different policy proposals which it says could minimize the global impact of antimicrobial resistance.
Off-Patent Personnel Moves In 2023 Reflect Growing Interest In Innovator Space
Executive changes at both Viatris and Teva in 2023 saw the companies shift their focus towards the innovator industry. Plus, trade groups saw some significant personnel shakeups, Alvotech expressed hope that new hires would help to resolve manufacturing approval issues, Biocon made changes to its management structure, and more.
A Year Of Change: Viatris Ploughs Ahead With Brand Ambitions
In 2024, Viatris will initiate the second phase of its long-term business plan, which will see it step away from the perceived volatility of the generics space and begin to move toward innovative and high-growth products. The past year has seen it lay the groundwork for this pivot, shedding surplus business units and making significant hires from the branded space.